Home > Insider Trading > Valeant Pharmaceuticals International

Valeant Pharmaceuticals International (VRX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
231 - 240
Next >>

Viking Global’s Top Five Picks for Q1 include Walgreen Company (WAG) & Time Warner Inc (TWX)

Last week, Andreas Halvorsen’s Viking Global, filed a Form 13F at the U.S. Securities and Exchange Commission, disclosing its equity positions as of March 31 2014.

Keep Reading →

May 22nd, 2014 - Hedge Funds News

Hedge Fund News: Ken Griffin, David Einhorn & Bill Ackman

The asset management industry is playing US regulators against their international counterparts and stirring national sentiment on Capitol Hill in an attempt to head off new regulation of its biggest ...

Keep Reading →

May 19th, 2014 - Hedge Funds

Hedge Fund News: Jim Chanos, Thomas Steyer & Carl Icahn

Short-seller James Chanos said he’s betting against shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) -2.92% amid its unsolicited $46 billion bid for Allergan, Inc.

Keep Reading →

May 15th, 2014 - Hedge Funds

ValueAct Capital Buys More Than $116 Million in Microsoft (MSFT) Shares

On Monday May 12, ValueAct Capital, managed by Jeffrey Ubben, declared the purchase of more than 2.95 million shares of Microsoft Corporation (NASDAQ:MSFT), which already is the fund’s most valuable...

Keep Reading →

May 13th, 2014 - Hedge Funds Insider Trading News

Hedge Fund News: Bill Ackman, Steven Heinz & Sac Capital Advisors

Three weeks ago Quebec based pharmaceuticals company Valeant Pharmaceuticals Intl Inc (NYSE:VRX) made a US$47 billion hostile takeover bid, in cash and stock, to acquire Irvine California based specialty...

Keep Reading →

May 12th, 2014 - Hedge Funds

Hedge Fund News: Bill Ackman, Crispin Odey & David Tepper

Canada’s largest pharmaceutical company and the U.S. activist investor who overhauled CP Rail have joined forces in a mega-deal to buy Allergan, Inc.

Keep Reading →

April 22nd, 2014 - Hedge Funds

Pershing Square Forms Joint Entity with Valeant Pharmaceuticals International Inc (VRX) to Acquire Allergan, Inc. (AGN)

Bill Ackman's Pershing Square has added Allergan, Inc. (NYSE:AGN) to its equity portfolio.

Keep Reading →

April 22nd, 2014 - Hedge Funds News

Kenneth Squire’s 13D Management Is Betting on These Stocks

13D Management is a New-York firm that was founded by Kenneth Squire in 2011. The fund, an event driven asset manager, focused on imitating activist investors.

Keep Reading →

March 18th, 2014 - Hedge Funds News

Hound Partners & Arrow Capital Management Are Buying the Same Stocks

Jonathan Auerbach co-founded long/short equity fund Hound Partners with Scott McLellan in 2004, seeded by Tiger Management.

Keep Reading →

March 7th, 2014 - Hedge Funds News

Nehal Chopra's Ratan Capital is Betting on These Stocks

Nehal Chopra is a graduate from the Wharton School of the University of Pennsylvania. In 2011, Tiger Management, led by Julian Robertson, seeded Nehal Chopra’s Ratan Capital.

Keep Reading →

February 24th, 2014 - Hedge Funds News